Skip to main content
Clinical Trials/ACTRN12613000542796
ACTRN12613000542796
Active, Not Recruiting
Phase 3

Application of structured interventions to improve quality of life in head and neck cancer survivors: a randomised trial

Associate Professor Jane Turner0 sites120 target enrollmentMay 15, 2013

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Mental Health
Sponsor
Associate Professor Jane Turner
Enrollment
120
Status
Active, Not Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 15, 2013
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Associate Professor Jane Turner

Eligibility Criteria

Inclusion Criteria

  • Patients eligible for this study must have a diagnosis of head and neck cancer and must have undergone treatment at one of the participating sites
  • \*Aged 18 years or over
  • \*Have within the past month completed a defined treatment protocol for cancer of the tongue, mouth, salivary glands. pharynx, the oro\-, hypo\- and nasopharynx, nasal cavities, middle ear, sinuses or larynx
  • Within the past month have completed a defined treatment protocol for non\-melanoma skin cancers of the head and neck requiring treatment known to cause toxicity (for example, combinations of surgery, radiotherapy or chemotherapy).
  • \*Able to speak and read English
  • \*Physical, cognitive and mental status such that can participate in the study

Exclusion Criteria

  • \*Inability to speak and read English
  • \*Receiving low\-toxicity treatment for head and neck cancer (for example laser therapy alone)
  • \*Presence of severe mental, cognitive or physical conditions with would limit the person’s ability to participate in the study, or which require ongoing regular specialist treatment
  • Advanced disease if life expectancy is considered to be less than 6 months

Outcomes

Primary Outcomes

Not specified

Similar Trials